Elanco Animal Health Incorporated (ELAN)
| Market Cap | 14.37B |
| Revenue (ttm) | 2.92B |
| Net Income (ttm) | -246.80M |
| Shares Out | 462.40M |
| EPS (ttm) | -0.60 |
| PE Ratio | n/a |
| Forward PE | 32.89 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 22 |
| Last Price | $30.46 |
| Previous Close | $30.39 |
| Change ($) | 0.07 |
| Change (%) | 0.23% |
| Day's Open | 30.02 |
| Day's Range | 29.93 - 30.93 |
| Day's Volume | 1,873,633 |
| 52-Week Range | 16.68 - 33.79 |
Elanco is one of a few large, independent animal health companies and this type of company is very hard to build from scratch.
Pharmaceutical stocks have many benefits, particularly when their products are in demand. And in 2021, that seems likely to be the case.
Elanco Animal Health Incorporated (ELAN) CEO Jeffrey Simmons Presents at 39th Annual JPMorgan Virtual Healthcare Brokers Conference (Transcript)
GREENFIELD, Ind.--(BUSINESS WIRE)--Today Elanco Animal Health Incorporated (NYSE: ELAN) announced that executive vice president of Transformation and Technology, Sarena Lin, will take a role o...
Bitcoin, Walgreens, Elanco Animal Health and Garmin were our top stock trades for Thursday. Let's have a look at what the charts are saying.
Elanco outlined its latest financial targets at a recent investor day event. The innovation engine is in full swing, and if it delivers, I see plenty of upside to the conservative top-line tar...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021. Jeff Simmo...
Spending on pets is a $100 billion industry. Here's how you can take advantage.
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today will host its Investor Day, where the executive leadership team will outline the company's strengthened ...
SAN DIEGO, Dec. 15, 2020 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NYSE: ELAN shares. Investors, who purchased shares o...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it has appointed distinguished healthcare executive, animal health director and investor ...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced an agreement with Kindred Biosciences (NASDAQ: KIN) to acquire exclusive global rights to KIND...
GREENFIELD, Ind.--(BUSINESS WIRE)--After a rigorous multi-state search, Elanco Animal Health, Inc. (NYSE: ELAN) today announced Indiana as its base for future global consolidated operations, a...
Elanco Animal Health, Inc. (ELAN) Presents at Evercore ISI HealthCONx Broker Conference Call - (Transcript)
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it will host a virtual investor day on Tuesday, December 15, 2020. The event will feature...
Elanco Animal Health Inc (NYSE: ELAN) in a filing with the U.S. Securities and Exchange Commission on Monday disclosed that German pharma and life sciences company Bayer AG (OTC: BAYRY) is off...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced the pricing of the previously announced public offering of 54,500,000 shares of its common sto...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) announced today the launch of a public offering of 54,500,000 shares of its common stock held by Bayer World I...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 3rd Annual Evercore ISI Virtual HealthCONx Conference on Tuesday, December 1, 2020. Je...
A new president will provide new opportunities for investors.
Elanco Animal Health Incorporated (ELAN) CEO Jeffrey Simmons on Credit Suisse 29th Annual Virtual Healthcare Conference (Transcript)
Elanco Animal Health Incorporated's (ELAN) CEO Jeff Simmons on Credit Suisse 29th Annual Virtual Healthcare Conference - Quick Version Earnings Call Transcript
Elanco Animal Health Incorporated's (ELAN) CEO Jeffrey Simmons on Q3 2020 Results - Earnings Call Transcript
Elanco Animal Health posted third-quarter earnings that edged views after completing its big Bayer Animal Health acquisition, but its sales and sales guidance lagged views. ELAN stock fell.
Shares of Elanco Animal Health (NYSE:ELAN) rose 0.1% in pre-market trading after the company reported Q3 results.
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported its financial results for the third quarter of 2020 and provided guidance for the fourth quarte...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Credit Suisse 29th Annual Virtual Healthcare Conference on Monday, November 9, 2020. J...
GREENFIELD, Ind.--(BUSINESS WIRE)--With the U.S. Food and Drug Administration (FDA) approval of Elura™ (capromorelin oral solution), a new prescription medication to manage weight loss in cats...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced its first sustainability commitments, just two years after becoming an independent company. Th...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (“Elanco”) (NYSE: ELAN) has received a notification of an unsolicited “mini-tender” offer by TRC Capital Investment Corpora...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2020 financial results on Friday, November 6, 2020. Elanco will also conduct a...
You don't need to start with a fortune to chart a path toward financial independence.
Hedge fund Sachem Head Capital Management has built a $1.2 billion stake in Elanco Animal Health Inc and plans to push for changes at the company that makes medicines and vaccinations for pets...
Elanco Animal Health Inc. ELAN, -1.10% said Wednesday it is restructuring its business just two months after closing the acquisition of Bayer Animal Health. The Greenfield, Indiana-based compa...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE:ELAN) today announced its first business restructuring just two months following the closing of its acquisition of Ba...
A vacillating stock market can be your friend if you have cash at the ready and a long-term mindset.
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Morgan Stanley 18th Annual Global Healthcare Conference on Tuesday, September 15, 2020.
The acquisition of Bayer Animal Health establishes Elanco as the second-largest animal health company in the world.
Elanco Animal Health (NYSE: ELAN) shares are trading higher on Thursday after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and announced a price target of $31 per share.
Elanco Animal Health Inc (NYSE: ELAN) shares are trading higher on Tuesday after Goldman Sachs reinstated a Buy rating on the stock and announced a price target of $26.50 per share.
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has closed the acquisition of Bayer Animal Health.
Elanco Animal Health Incorporated (ELAN) CEO Jeff Simmons on Q2 2020 Results - Earnings Call Transcript
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 350.00% and 5.48%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ah...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported its financial results for the second quarter of 2020.
Elanco (ELAN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectati...
New York, New York--(Newsfile Corp. - July 20, 2020) - Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Elanco Animal Health Incorporated...
Los Angeles, California--(Newsfile Corp. - July 20, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Elanco An...
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Elanco Animal Health Incorporated (NYSE: ELAN) between January 10, 2020 an...
NEW ORLEANS, July 19, 2020 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only ...
About ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for companion and food animals. It offers companion animal disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as ... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Sep 20, 2018 |
| CEO Jeffrey N. Simmons | Employees 6,080 |
| Stock Exchange NYSE | Ticker Symbol ELAN |
Financial Performance
In 2019, ELAN's revenue was $3.07 billion, an increase of 0.14% compared to the previous year's $3.07 billion. Earnings were $67.90 million, a decrease of -21.50%.
Analyst Forecasts
According to 16 analysts, the average rating for ELAN stock is "Buy." The 12-month stock price forecast is 32.20, which is an increase of 5.71% from the latest price.